There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (1)

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

Expressing the sense of the House of Representatives that there is need for further study of the Functional Gastrointestinal Disorder (FGID) Irritable Bowel Syndrome (IBS).


Actions Overview (1)

Date
04/29/2010Introduced in House

All Actions (6)

Date
05/06/2010Referred to the Subcommittee on Military Personnel.
04/29/2010Referred to House Veterans' Affairs
04/29/2010Referred to House Armed Services
04/29/2010Referred to House Energy and Commerce
04/29/2010Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/29/2010Introduced in House

Committees (3)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce04/29/2010 Referred to
House Armed Services04/29/2010 Referred to
House Armed Services Subcommittee on Military Personnel05/06/2010 Referred to
House Veterans' Affairs04/29/2010 Referred to

No related bill information was received for H.Res.1309.


Subjects (7)


Latest Summary (1)

There is one summary for H.Res.1309. View summaries

Shown Here:
Introduced in House (04/29/2010)

Calls for the Director of the National Institutes of Health (NIH) to take a leadership role in the search for new treatment options and a cure for Irritable Bowel Syndrome (IBS) by: (1) encouraging the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to implement the research recommendations of the National Commission on Digestive Diseases; (2) exploring collaborative research opportunities between the NIDDK, the Office of Research on Women's Health, and other NIH Institutes and Centers; and (3) encouraging NIDDK to provide the necessary funding for continued expansion and advancement of the IBS research portfolio and for education with respect to IBS and Functional Gastrointestinal Disorders (FGIDs) through the cosponsorship of workshops and seminars with patient organizations.

Expresses the sense of the House of Representatives that: (1) funding should be increased for basic and clinical biomedical research into IBS and other FGIDs through NIH; (2) the Director of the Food and Drug Administration (FDA) should take a leadership role in ensuring that new IBS treatments are developed and appropriately monitored; and (3) the Department of Defense (DOD) and the Department of Veterans Affairs (VA) should bolster their efforts to study IBS and FGIDs and their association with war trauma.